Abstract:Objective To investigate the safety and effectiveness of radiofrequency ablation ( RFA ) in the treatment of bone metastases. Methods From November 2008 to December 2012, 19 patients with bone metastases were treated with RFA in our department. There were 10 males and 9 females with an average age of 57 years old ( range;41-76 years ). Lung carcinoma was the most common primary tumor ( n=11 ), followed by kidney carcinoma ( n=2 ), breast carcinoma ( n=1 ), thyroid carcinoma ( n=1 ), rectal carcinoma ( n=1 ), gastric carcinoma ( n=1 ), hepatocellular carcinoma ( n=1 ) and unknown carcinoma ( n=1 ). There were totally 21 lesions in the 19 patients, including 9 lesions in the femur, 6 lesions in the pelvis, 5 lesions in the humerus and 1 lesion in the tibia. Curettage and reconstruction after the RFA were performed for 16 lesions. Percutaneous RFA was performed for 5 lesions, and 3 of them in the femoral shaft were ifxed with intramedullary nails. During the follow-up, the pain scores and function scores were used to evaluate the effects and check the recurrence and the safety of the surgery. There were 2 kinds of evaluation methods. ( 1 ) The preoperative and postoperative pain scores were compared ( numerical rating scale ). ( 2 ) The function evaluation of the patients whose survival time was more than 6 months was performed ( the Musculoskeletal Tumor Society MSTS rating scale ). Results The mean follow-up period was 10 months (range;1-32 months ) and the mean survival time was 9.7 months ( range;1-32 months ). Fifteen patients were dead. The mean pain score was 8.1 points before the surgery and 2.2 points and 2.7 points at 1 week and 3 months after the surgery respectively, and there were statistically signiifcant differences before and after the surgery ( P<0.01 ). Local pain recurred in 1 patient at 6 months after the ablation with the pain score of 7 points, who received oral analgesic but died 11 months later due to the progress of primary tumors. One patient had thermal damage around the skin adjacent to the tourniquet during the surgery and 1 patient developed wound necrosis after the surgery. The function evaluation was performed in 12 patients whose survival time was more than 6 months, and the excellent and good rate was 83.3%. Conclusions The RFA is a safe and effective approach in the palliative treatment of bone metastases. The local pain can be relieved and the development of bone metastases can be controlled.

Mid-term Efficacy Grading Evaluation and Predictive Factors of Magnetic Resonance–guided Focused Ultrasound Surgery for Painful Bone Metastases: a Multi-Center Study

Safety and Short-Term Efficacy of MR Guided Focused Ultrasound Surgery for Bone Metastasis-Induced Pain Palliation

The Effect of Pelvic Floor Magnetic Stimulation in Women with Myofascial Pelvic Pain Syndrome: A Prospective Cohort Pilot Study

Multicenter Prospective Clinical Series Evaluating Radiofrequency Ablation in the Treatment of Painful Spine Metastases

Palliative pain relief and safety of percutaneous radiofrequency ablation combined with cement injection for bone metastasis

Clinical efficacy and safety of bone cement combined with radiofrequency ablation in the treatment of spinal metastases

Radiofrequency ablation versus magnetic resonance guided focused ultrasound surgery for minimally invasive treatment of osteoid osteoma: a propensity score matching study

Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastases

MR-guided Focused Ultrasound for Musculoskeletal Applications

3-T magnetic resonance–guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors

CT-guided Percutaneous Minimally Invasive Radiofrequency Ablation for the Relief of Cancer Related Pain from Metastatic Non-Small Cell Lung Cancer Patients: a Retrospective Study.

A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions

The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases

Learning Multiparametric Biomarkers for Assessing MR-Guided Focused Ultrasound Treatment of Malignant Tumors

Update on musculoskeletal applications of magnetic resonance-guided focused ultrasound

MR-guided Focused Ultrasound Thalamotomy for Chronic Pain

MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients

Post‐prostatectomy Magnetic Resonance‐guided Radiotherapy on a 1.5 Tesla Magnetic Resonance Integrated Linear Accelerator: Feasibility, Toxicity, and Preliminary Clinical Outcomes

Multicenter clinical and imaging evaluation of targeted radiofrequency ablation (t-RFA) and cement augmentation of neoplastic vertebral lesions

A application of radiofrequency ablation in the palliative treatment of bone metastases

Combination of Microwave Ablation and Percutaneous Osteoplasty for Treatment of Painful Extraspinal Bone Metastasis